This site is intended for Healthcare Professionals only.

Sensyne Health appoints former MHRA boss as non-executive director


Share post:

Sensyne Health has announced the appointment of Dr Ian Hudson to the Board as it independent non-executive director.

Effective from June 28, Hudson will lead the Oxford-based clinical Artificial Intelligence (AI) company as a non-executive director, Sensyne said on Friday (June 18).

Hudson has extensive knowledge of the healthcare and pharmaceutical sector, having served as chief executive of the Medicines and Healthcare Products Regulatory Agency (MHRA) from 2013 to 2019.

Prior to joining the MHRA, Hudson held various senior roles at GSK when it was known as SmithKline Beecham, working for more than a decade in clinical research and development.

He is currently serving as senior advisor, Integrated Development for the Bill and Melinda Gates Foundation.

Hudson’s working areas include optimising clinical studies and strengthening regulatory systems in low-resource regions, as well as providing regulatory input to teams working on malaria, polio, and Covid-19 drugs.


Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Head lice cases on the rise across the UK, warns Superdrug

If lotions or sprays prove ineffective, consulting a pharmacist about alternative head lice treatments is recommended Parents are...

Gender identity services: GPhC publishes new resource for pharmacy professionals

The regulatory body sets out questions that pharmacy professionals should ask themselves when providing gender identity care  The General...

NHS patient safety initiative: 143 hospitals across England to roll out Martha’s Rule

This programme has the opportunity to truly transform “patient care and safety” NHS England has confirmed the initial sites...

Why You Shouldn’t Delay in Filing a Medical Malpractice Claim

When faced with the unfortunate situation of medical malpractice, it’s understandable that you may feel overwhelmed and uncertain...